Attached files
| file | filename |
|---|---|
| EX-10.9 - EX-10.9 - Paratek Pharmaceuticals, Inc. | prtk-ex109_74.htm |
| EX-10.14 - EX-10.14 - Paratek Pharmaceuticals, Inc. | prtk-ex1014_457.htm |
| EX-23.1 - EX-23.1 - Paratek Pharmaceuticals, Inc. | prtk-ex231_12.htm |
| EX-31.1 - EX-31.1 - Paratek Pharmaceuticals, Inc. | prtk-ex311_9.htm |
| EX-32.1 - EX-32.1 - Paratek Pharmaceuticals, Inc. | prtk-ex321_8.htm |
| EX-32.2 - EX-32.2 - Paratek Pharmaceuticals, Inc. | prtk-ex322_10.htm |
| EX-31.2 - EX-31.2 - Paratek Pharmaceuticals, Inc. | prtk-ex312_6.htm |
| EX-10.50 - EX-10.50 - Paratek Pharmaceuticals, Inc. | prtk-ex1050_415.htm |
| 10-K - 10-K - Paratek Pharmaceuticals, Inc. | prtk-10k_20201231.htm |
Exhibit 21.1
Paratek Pharmaceuticals, Inc.
Subsidiaries
Paratek Ireland Limited
Paratek Pharma, LLC
Paratek Royalty Corporation
Paratek Royalty Corporation II
Paratek Securities Corporation
Paratek UK Limited
PRTK SPV1 LLC
PRTK SPV2 LLC
Transcept Pharma, Inc.